ArticleCancer medicine2020

Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China.

Wen Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.